feed,title,long_url,short_url
GN:S:RL,Insilico Medicine Announces Novel 3CL Protease Inhibitor Preclinical Candidate for COVID-19 Treatment USA - English - USA - English - PR Newswire,https://www.prnewswire.com/news-releases/insilico-medicine-announces-novel-3cl-protease-inhibitor-preclinical-candidate-for-covid-19-treatment-301553766.html,https://prn.to/3yXNBF6
